Clinical Trial: BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135271) titled 'BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer' on Aug. 11.

Brief Summary: The goal of this randomised clinical trial is to assess whether personalised treatment counselling can improve the decision-making experience in patients with a new diagnosis of localised prostate cancer. The main question it aims to answer is:

* Does the Bespoke Decision Support tool reduce decisional conflict in those choosing between treatment options for localised prostate cancer?

Researchers will compare the addition of the Bespoke Decision Support tool to standard treatment counselling versus standard counselling ...